Up to now, the mechanisms observed widely for PI3K/AKT activation in gastric cancer include somatic activating mutations and amplifications in p110α (6–8), loss of the PTEN tumor suppressor (8), and genetic amplifications of AKT1 (9). The gene discussed is PTEN; the disease is gastric cancer.